First party and third-party cookies
We place some of the cookies on your device ourselves (first party cookies), while other cookies are placed by third parties (third-party cookies), see the column ‘Provider’ in the cookie tables above for specific information per cookie.
Which cookies do we use?
Certain cookies are necessary for the functioning of the Platform. We use the following necessary cookies, also known as functional cookies:
|PHPSESSID||Website||Preserves user session state across page requests||session|
|CookieConsent||Website||Stores the user’s cookie consent state for the current domain||1 year|
Other cookies allow us to further develop and improve the functionality of our Platform by analyzing your use of our website, analytical cookies, also known as statistical cookies. This can improve the speed in which we can process your request. These cookies channel back information to our data analytics tool, Google Analytics from Google LLC (Google).
We receive information on how you use and interact with our website, as well as on the amount of time that you spend on it. We also collect basic information that relates to the request that is made from your browser when you visit the Platform. These data may include the following information:
your last visit date and time;
the duration of your visit;
the timestamp of the browser request;
your IP address and basic HTTP header information (like referral URL and user agent); and/or
information about a website you have previously visited as well as demographic information.
We use Google Tag Manager to place and manage cookies and scripts.
We have followed the Manual for Privacy Friendly Google Analytics Settings of the Dutch Data Protection Authority for the use of Google Analytics. This means, among other things, that we have instructed Google to delete the last three digits of your IP address (making it difficult to trace the IP address to a specific user/visitor) and that we have disabled the default settings for sharing data with Google. In addition, we have entered into a data processing agreement with Google. We do not use any other Google services in combination with the Google Analytics cookies. The limited information that is shared with Google using Google Analytics can be transferred to and stored by Google on servers in the United States.
We use the following analytical (statistical) cookies:
|_ga||Registers a unique ID that is used to generate statistical data on how the visitor uses the website.||2 years|
|_gat||Used by Google Analytics to throttle request rate.||1 day|
|_gid||Registers a unique ID that is used to generate statistical data on how the visitor uses the website.||1 day|
Enabling, disabling, and deleting cookies
Cookies that have a specific duration will remain on your device until that term expires, unless you manually delete them before the expiry date. You can use your browser settings to delete the cookies on your device and refuse the placement of new cookies. This can vary per browser. To learn more, please look at the cookie settings available in your specific web browser(s). The links below will take you directly to the manuals of commonly used browsers:
- Google Chrome
- Internet Explorer
- Safari and more specifically for your Apple devices.
Furthermore, if you do not want Google Analytics data to be collected and used by Google, you can download and install the browser plugin that is available under: https://tools.google.com/dlpage/gaoptout. More information on how to remove cookies as well as information on cookies generally can also be found at: www.youronlinechoices.eu.
If you decide to delete all cookies, you will be asked to indicate your cookie preferences on our Platform on your next visit.
European Hematology Association
2514 AA The Hague, The Netherlands
European patient survey on CAR T-cell therapy to gain insights into patients’ experiences, quality of life and unmet needs
All European adult patients who received CAR T-cell therapy for a hematologic malignancy can participate by filling in a digital survey.
Next week, the T2EVOLVE and QUALITOP consortia will launch a survey developed to understand, analyze and meet the needs of European patients treated with CAR-T therapy for hematological cancers. To reach and engage as many patients as possible, T2EVOLVE's Work Package...